HZNP

Horizon Pharma plc Press Releases

$12.78
*  
0.11
0.85%
Get HZNP Alerts
*Delayed - data as of Nov. 28, 2014  -  Find a broker to begin trading HZNP now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Horizon Pharma plc to Present at the 26th Annual Piper Jaffray Healthcare Conference
11/24/2014 8:00:00 AM - Market Wire


Horizon Pharma plc Announces Presentation of Data Showing Unmet Need in Rheumatoid Arthritis and the Positive Effect of RAYOS(R) (Prednisone) Delayed-Release Tablets in Reducing Joint Stiffness of RA Throughout the Day
11/18/2014 4:05:00 PM - Market Wire


Horizon Pharma plc Announces Pricing of Secondary Offering of Ordinary Shares by Selling Shareholders
11/14/2014 8:00:00 AM - Market Wire
▲4.33 % Price Change since this news event. The Volume Ratio is 4.4.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Horizon Pharma plc Announces Proposed Secondary Offering of Ordinary Shares by Selling Shareholders
11/13/2014 7:00:00 AM - Market Wire
▼-2.44 % Price Change since this news event. The Volume Ratio is 1.3.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Horizon Pharma plc Announces Clinical Data on RAYOS(R) (Prednisone) Delayed-Release Tablets and VIMOVO(R) (Naproxen/Esomeprazole Magnesium) to Be Presented at the American College of Rheumatology Annual Meeting
11/12/2014 4:05:00 PM - Market Wire
▼-2.44 % Price Change since this news event. The Volume Ratio is 1.28.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Horizon Pharma plc Announces Favorable Markman Ruling in RAYOS(R) (prednisone) Delayed-Release Tablets Patent Infringement Litigation
11/12/2014 8:00:00 AM - Market Wire
▼-2.07 % Price Change since this news event. The Volume Ratio is 0.52.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Horizon Pharma plc to Present at the Stifel 2014 Healthcare Conference
11/11/2014 4:05:00 PM - Market Wire
▼-2.07 % Price Change since this news event. The Volume Ratio is 0.52.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Horizon Pharma plc Reports Third Quarter 2014 Financial Results and Raises Guidance for 2014 and 2015
11/6/2014 7:00:00 AM - Market Wire
▲3.40 % Price Change since this news event. The Volume Ratio is 2.14.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Horizon Pharma plc Appoints John J. Kody as Executive Vice President and Chief Commercial Officer
11/6/2014 6:30:00 AM - Market Wire
▲3.40 % Price Change since this news event. The Volume Ratio is 2.14.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Horizon Pharma plc Announces DUEXIS(R) Selected as Winner of Chicago Innovation Award
10/31/2014 8:00:00 AM - Market Wire
▲0.24 % Price Change since this news event. The Volume Ratio is 1.8.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Lawson Products Reports Third Quarter 2014 Results
10/23/2014 7:30:00 AM - Business Wire


TransEnterix Schedules Third Quarter 2014 Earnings Release and Conference Call for November 6, 2014
10/23/2014 7:30:00 AM - Business Wire


Horizon Pharma plc to Host Third Quarter 2014 Conference Call and Webcast on November 6, 2014
10/21/2014 4:05:00 PM - Market Wire
▲4.41 % Price Change since this news event. The Volume Ratio is 0.69.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Horizon Pharma plc Announces Acquisition of U.S. Rights to PENNSAID(R) 2% From Nuvo Research Inc.
10/17/2014 7:00:00 AM - Market Wire
▲13.20 % Price Change since this news event. The Volume Ratio is 0.75.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Horizon Pharma plc Reviews Future ACTIMMUNE(R) Opportunities at Analyst Day
10/13/2014 5:00:00 PM - Market Wire
▲16.61 % Price Change since this news event. The Volume Ratio is 1.98.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Horizon Pharma plc Announces Presentation of ACTIMMUNE(R) Phase 2 Data in Friedreich's Ataxia
10/9/2014 1:37:00 PM - Market Wire
▲5.79 % Price Change since this news event. The Volume Ratio is 2.54.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Horizon Pharma plc Receives Orphan-Drug Designation for ACTIMMUNE(R) (Interferon gamma-1b) in Friedreich''s Ataxia
10/3/2014 4:00:00 PM - Market Wire


Horizon Pharma plc Receives Orphan-Drug Designation for ACTIMMUNE(R) (Interferon gamma-1b) in Friedreich's Ataxia
10/3/2014 4:00:00 PM - Market Wire


Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of Additional Notice of Allowance With Claims Covering VIMOVO(R) (naproxen/esomeprazole) Delayed Release Tablets
10/1/2014 8:00:00 AM - Market Wire


Horizon Pharma plc Announces Management Executive Committee and Commercial Restructuring Following Close of Acquisition of Vidara Therapeutics International plc
9/26/2014 9:00:00 AM - Market Wire


Horizon Pharma plc to Host Friedreich''s Ataxia Analyst Day on October 13, 2014
9/23/2014 4:05:00 PM - Market Wire


Horizon Pharma plc to Host Friedreich's Ataxia Analyst Day on October 13, 2014
9/23/2014 4:05:00 PM - Market Wire


Horizon Pharma to Present at the 21st Annual NewsMakers in the Biotech Industry Conference
9/22/2014 4:05:00 PM - Market Wire


Horizon Pharma plc Announces Board of Directors Following Closing of Acquisition of Vidara Therapeutics International plc
9/19/2014 10:46:00 AM - Market Wire


Horizon Pharma Completes Acquisition of Vidara Therapeutics International plc
9/19/2014 10:42:00 AM - Market Wire